Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

Early hair loss may indicate prostate issues.

Minoxidil and caffeine in transfersomes improve hair growth treatment.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Latanoprost, a glaucoma drug, showed potential for promoting hair growth in bald monkeys, especially at higher doses.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Serenoa repens extract in topical products improves hair growth and appearance in male pattern baldness with mild side-effects.

Chitosan-decorated finasteride nanosystems improve skin retention and could be a better treatment for hair loss.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Combining low-level laser therapy with minoxidil doesn't improve hair loss treatment compared to using minoxidil alone.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

Tadalafil and Finasteride may help treat aggressive melanoma.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Finasteride may cause slight depression and anxiety.

A man got a scalp infection from synthetic hair implants because the procedure wasn't done by a doctor and was poorly managed.

Transfersomes are better than liposomes for targeting hair follicles in alopecia treatment.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.